Tag: Pi-Cardia

Pi-Cardia closes a US$27 million financing round led by Sofinnova Partners

Pi-Cardia has closed a US$27 million round of financing, led by Sofinnova Partners. A press rele...

Leaflex Performer: A non-implant based treatment for aortic stenosis

Given sufficient time, all bioprosthetic valves fail—whether they are surgical or transcatheter ...

EuroPCR 2018: First-in-human study of Leaflex Performer for aortic stenosis initiated

Pi-Cardia has recently started its first-in-human study with its Leaflex Performer catheter system. ...